Sponsored Links
| HemaQuest Pharmaceuticals Initiates Phase 2 Clinical Trial In EBV-Related Malignancies |
 |
 |
 |
| Medical News - Lymphology and Lymphedema | |||
|
HemaQuest Pharmaceuticals announced that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival... Read more: Lymphology/Lymphedema News From Medical News Today
|